GPNMB and Alzheimer disease: Given their detection and confirmation of GPNMB ECF in the CSF of AD patients, the authors contend that GPNMB is a viable biomarker for AD but caution that less sensitive approaches to mass spectrometry may miss a majority of the proteins detected in the AD CSF proteome.